Equities

SWS Hemodialysis Care Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

SWS Hemodialysis Care Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)17.07
  • Today's Change-0.06 / -0.35%
  • Shares traded5.03m
  • 1 Year change+65.89%
  • Beta--
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

SWS Hemodialysis Care Co Ltd is a China-based company mainly engaged in the research, development, production and sales of blood purification equipment and consumables. The Company's products include continuous blood purification equipment, hemodialysis machines, hemoperfusion machines, as well as blood purification consumables such as hemodialysis concentrates, hemodialysis powders, dialyzers, dialysate filters, continuous blood purification tubing, and disposable hemoperfusion machines. The Company's products are widely used in the treatment of various diseases such as acute and chronic renal failure, uremia, multiple organ failure and poisoning. The Company also provides chain hemodialysis medical services.

  • Revenue in CNY (TTM)733.59m
  • Net income in CNY113.43m
  • Incorporated2001
  • Employees1.10k
  • Location
    SWS Hemodialysis Care Co LtdNo. 1 Ciji Road, LiangJiang New DistrictCHONGQING 401123ChinaCHN
  • Phone+86 2 367460800
  • Fax+86 2 368690058
  • Websitehttps://www.swskj.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Zhejiang Orient Gene Biotech Co Ltd842.11m-479.50m4.89bn2.28k--0.7692--5.81-2.48-2.484.3731.550.1071.443.39369,997.60-6.6821.19-7.7726.7434.8858.52-62.4332.423.86--0.046224.780.94617.65-33.06--138.80--
Hangzhou Ags Medtech Co Ltd668.70m272.95m4.98bn744.0018.222.00--7.453.373.378.2530.670.26733.3111.94898,793.6010.91--11.39--69.67--40.82--18.27--0.001--25.14--35.06------
CareRay Digital Medical Technology CoLtd328.62m5.41m5.01bn282.00872.105.83--15.230.06510.06513.799.740.33921.693.661,165,314.000.53624.810.59725.2736.1340.001.5812.873.571.770.049734.948.904.9114.54-18.1985.59--
Assure Tech (Hangzhou) Co Ltd462.72m120.87m5.06bn741.0041.860.98--10.930.95110.95113.6440.620.08092.222.17624,449.302.1123.692.3028.0130.3264.6126.1147.6511.28--0.001218.787.4220.8535.8528.6963.16--
Hangzhou Biotest Biotech Co Ltd478.69m102.57m5.38bn603.0051.742.30--11.240.69640.69643.0615.660.19133.205.70793,854.104.0223.634.2526.2050.5756.5921.0041.4713.08--0.0000834.4226.5321.7859.0143.1244.08--
Nanjing Vishee Medical Technology Co Ltd433.83m125.95m5.39bn639.0042.823.25--12.431.321.324.5317.310.24114.0014.42678,922.307.008.397.639.2061.2471.6229.0332.766.54--0.018259.13-13.454.64-25.160.447439.73--
SWS Hemodialysis Care Co Ltd733.59m113.43m5.47bn1.10k48.423.11--7.460.35380.35382.295.520.35772.806.23665,688.205.235.685.836.5445.7145.7914.6116.065.25--0.001428.46-17.8031.86-63.55--24.70--
Shanghai Aohua Phtlctrcty Endscp Co Ltd671.62m-72.38m5.75bn1.22k--4.62--8.56-0.5475-0.54755.109.250.38341.022.29552,775.60-4.143.01-5.153.3461.7968.86-10.807.521.57--0.208643.3010.5420.28-63.68-16.8623.29--
Shenzhen Lifotronic Technology Co Ltd1.05bn251.02m5.90bn1.67k23.332.81--5.600.59070.59072.474.900.38552.515.74631,202.608.9814.0312.1017.3461.0362.4623.3027.253.00--0.140639.010.202422.125.1227.99-1.6318.64
Jiangsu Bioperfectus Technologies Co Ltd339.03m-25.96m5.91bn592.00--1.99--17.43-0.3096-0.30964.0435.380.09031.856.13572,683.70-0.691920.36-0.79624.5558.2262.71-7.6631.893.22--0.132928.76-13.293.9099.46---9.88--
Qingdao NovelBeam Technology Co Ltd571.80m174.33m6.00bn841.0034.464.55--10.491.451.454.7610.990.38170.99325.67679,901.1011.3912.7012.6114.1164.3463.1529.8433.963.4351.040.105840.95-5.9011.86-7.1113.4813.44--
Data as of Feb 06 2026. Currency figures normalised to SWS Hemodialysis Care Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

9.77%Per cent of shares held by top holders
HolderShares% Held
Fullgoal Fund Management Co., Ltd.as of 30 Jun 20255.17m2.21%
Bosera Asset Management Co., Ltd.as of 30 Jun 20254.81m2.05%
Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 20252.91m1.24%
HFT Investment Management Co., Ltd.as of 30 Jun 20252.24m0.96%
ICBC UBS Asset Management Co. Ltd.as of 30 Jun 20252.11m0.90%
China Southern Asset Management Co., Ltd.as of 30 Jun 20251.53m0.65%
New China Fund Management Co., Ltd.as of 30 Jun 20251.49m0.64%
China Merchants Fund Management Co., Ltd.as of 30 Jun 20251.03m0.44%
Fuanda Fund Management Co., Ltd.as of 30 Jun 2025818.76k0.35%
CPIC Fund Management Co. Ltd.as of 30 Jun 2025792.67k0.34%
More ▼
Data from 30 Jun 2025 - 29 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.